click below
click below
Normal Size Small Size show me how
Medication Final
| Question | Answer |
|---|---|
| what is the brand name of acetaminophen | tylenol |
| what is the therapeutic class of acetaminophen | analgesic |
| what is the pharmacologic class of acetaminophen | analgesic |
| what is the brand name of aspirin | bayer aspirin |
| what is the therapeutic class of aspirin | analgesic |
| what is the pharmacologic class of aspirin | COX 1 inhibitor |
| what is the brand name of ibuprofen | advil |
| what is the therapeutic class of ibuprofen | analgesic |
| what is the pharmacologic class of ibuprofen | COX 1 inhibitor |
| what is the brand name of naproxen | aleve/anaprox |
| what is the therapeutic class of naproxen | analgesic |
| what is the pharmacologic class of naproxen | COX 1 inhibitor |
| what is the brand name of diclofenac | voltaren |
| what is the therapeutic class of diclofenac | analgesic |
| what is the pharmacologic class of diclofenac | COX 1 inhibitor |
| what is the brand name of celecoxib | celebrex |
| what is the therapeutic class of celecoxib | analagesic |
| what is the pharmacologic class of celecoxib | COX 2 inhibitor |
| what is the brand name of ketorolac | toradol |
| what is the therapeutic class of ketorolac | analgesic |
| what is the pharmacologic class of ketorolac | COX 1 inhibitor |
| what is the brand name of meloxicam | mobic |
| what is the therapeutic class of meloxicam | analgesic |
| what is the pharmacologic class of meloxicam | COX 1 inhibitor |
| what is the MOA of acetaminophen | blocks the arachadonic acid pathway |
| what is the MOA of aspirin | inhibits COX enzymes in AA pathway |
| what is the MOA of ibuprofen | inhibits COX enzymes in AA pathway |
| what is the MOA of naproxen | inhibits COX enzymes in AA pathway |
| what is the MOA of diclofenac | inhibits COX enzymes in AA pathway |
| what is the MOA of celecoxib | inhibits COX enzymes in AA pathway |
| what is the MOA of ketorolac | inhibits COX enzymes in AA pathway |
| what is the MOA of meloxicam | inhibits COX enzymes in AA pathway |
| what is a major characteristic of acetaminophen | hepatotoxicity |
| what is a major characteristic of aspirin | bleeding |
| what is a major characteristic of ibuprofen | bleeding |
| what is a major characteristic of naproxen | bleeding |
| what is a major characteristic of diclofenac | bleeding |
| what is a major characteristic of celecoxib | bleeding |
| what is a major characteristic of ketorolac | bleeding |
| what is a major characteristic of meloxicam | bleeding |
| what is the brand name of famotidine | pepcid |
| what is the therapeutic class of famotidine | anti-acid |
| what is the pharmacologic class of famotidine | H2RA |
| what is the brand name of sucralfate | carafate |
| what is the therapeutic class of sucralfate | GI protectant |
| what is the pharmacologic class of sucralfate | GI protectant |
| what is the brand name of omeprazole | prilosec |
| what is the therapeutic class of omeprazole | anti-acid |
| what is the pharmacologic class of omeprazole | proton pump inhibitor |
| what is the brand name of pantoprazole | protonix |
| what is the therapeutic class of pantoprazole | anti-acid |
| what is the pharmacologic class of pantoprazole | proton pump inhibitor |
| what is the brand name of esomeprazole | nexium |
| what is the therapeutic class of esomeprazole | anti-acid |
| what is the pharmacologic class of esomeprazole | proton pump inhibitor |
| what is the brand name of dexlansoprazole | dexilant |
| what is the therapeutic class of dexlansoprazole | anti-acid |
| what is the pharmacologic class of dexlansoprazole | proton pump inhibitor |
| what is the MOA of famotidine | blocks histamine receptor on parietal cells |
| what is the MOA of sucralfate | makes coating in stomach to protect the lining |
| what is the MOA of omeprazole | turns off cell so that it cant secrete acid |
| what is the MOA of lansoprazole | turns off cell so that it cant secrete acid |
| what is the MOA of pantoprazole | turns off cell so that it cant secrete acid |
| what is the MOA of esomeprazole | turns off cell so that it cant secrete acid |
| what is the MOA of dexlansoprazole | turns off cell so that it cant secrete acid |
| what is a major characteristic of famotidine | altered mental status |
| what is a major characteristic of sucralfate | impairs absorption |
| what is a major characteristic of omeprazole | rebound heartburn |
| what is a major characteristic of lansoprazole | rebound heartburn |
| what is a major characteristic of pantoprazole | rebound heartburn |
| what is a major characteristic of esomeprazole | rebound heartburn |
| what is a major characteristic of dexlansoprazole | rebound heartburn |
| what is the brand name of senna | senokot |
| what is the therapeutic class of senna | laxative |
| what is the pharmacologic class of senna | stimulant |
| what is the brand name of docusate | colace |
| what is the therapeutic class of docusate | laxative |
| what is the pharmacologic class of docusate | stool softener |
| what is the brand name of senna/docusate | senokot-s |
| what is the therapeutic class of senna/docusate | laxative |
| what is the pharmacologic class of senna/docusate | combo stimulant/softener |
| what is the brand name of polyethylene glycol 3350 | miralax |
| what is the therapeutic class of PEG 3350 | laxative |
| what is the pharmacologic class of PEG 3350 | osmotic |
| what is the brand name of bisacodyl | dulcolax |
| what is the therapeutic class of bisacodyl | laxative |
| what is the pharmacologic class of bisacodyl | stimulant |
| what is the brand name of magnesium citrate | n/a |
| what is the therapeutic class of magnesium citrate | laxative |
| what is the pharmacologic class of magnesium citrate | osmotic |
| what is the brand name of magnesium hydroxide | milk of magnesia |
| what is the therapeutic class of magnesium hydroxide | laxative |
| what is the pharmacologic class of magnesium hydroxide | osmotic |
| what is the brand name of fiber | fibercon |
| what is the therapeutic class of fiber | laxative |
| what is the pharmacologic class of fiber | bulk-forming |
| what is the MOA of senna | irritates the lining of the intestines to increase peristalsis |
| what is the MOA of docusate | reduces tension between water and fat in the stool |
| what is the MOA of senna/docusate | irritates intestine lining and softens stool |
| what is the MOA of PEG 3350 | draws water into the bowels to increase stool softness |
| what is the MOA of bisacodyl | irritates the lining of the intestines to increase peristalsis |
| what is the MOA of magnesium citrate | draws water into the bowels to increase stool softness |
| what is the MOA of magnesium hydroxide | draws water into the bowels to increase stool softness |
| what is the MOA of fiber | bulks the stool |
| what is a major characteristic of senna | GI cramping |
| what is a major characteristic of docusate | not that effective |
| what is a major characteristic of senna/docusate | GI cramping |
| what is a major characteristic of PEG 3350 | uncomfortable gas |
| what is a major characteristic of bisacodyl | cramping/diarrhea |
| what is a major characteristic of magnesium citrate | electrolyte disturbances |
| what is a major characteristic of magnesium hydroxide | electrolyte disturbances |
| what is a major characteristic of fiber | drink water or expect constipation |
| what is the brand name of allopurinol | aloprim |
| what is the therapeutic class of allopurinol | anti-gout |
| what is the pharmacologic class of allopurinol | xanthine oxidase inhibitor |
| what is the brand name of colchicine | colcrys |
| what is the therapeutic class of colchicine | anti-inflammatory |
| what is the pharmacologic class of colchicine | anti-inflammatory |
| what is the MOA of allopurinol | inhibits uric acid production |
| what is the MOA of colchicine | anti-inflammatory |
| what is the MOA of febuxostat | inhibits uric acid production |
| what is the brand name of febuxostat | uloric |
| what is the therapeutic class of febuxostat | antigout |
| what is the pharmacologic class of febuxostat | xanthine oxidase inhibitor |
| what is a major characteristic of allopurinol | risk of major rash |
| what is a major characteristic of colchicine | diarrhea at high doses |
| what is a major characteristic of febuxostat | BBW for cardiovascular death |
| what is the brand name of diphenhydramine | benadryl |
| what is the therapeutic class of diphenhydramine | anti-allergy |
| what is the pharmacologic class of diphenhydramine | 1st gen antihistamine |
| what is the brand name of doxylamine | unisom |
| what is the therapeutic class of doxylamine | insomnia |
| what is the pharmacologic class of doxylamine | 1st gen antihistamine |
| what is the brand name of hydroxyzine | atarax |
| what is the therapeutic class of hydroxyzine | anti-anxiety |
| what is the pharmacologic class of hydroxyzine | 1st gen antihistamine |
| what is the brand name of meclizine | antivert |
| what is the therapeutic class of meclizine | vertigo |
| what is the pharmacologic class of meclizine | 1st gen antihistamine |
| what is the brand name of cetirizine | zyrtec |
| what is the therapeutic class of cetirizine | anti-allergy |
| what is the pharmacologic class of cetirizine | 2nd gen antihistamine |
| what is the brand name of loratadine | claritin |
| what is the therapeutic class of loratadine | anti-allergy |
| what is the pharmacologic class of loratadine | 2nd gen antihistamine |
| what is the brand name of desloratadine | clarinex |
| what is the therapeutic class of desloratadine | anti-allergy |
| what is the pharmacologic class of desloratadine | 2nd gen antihistamine |
| what is the brand name of fexofenadine | allegra |
| what is the therapeutic class of fexofenadine | anti-allergy |
| what is the pharmacologic class of fexofenadine | 2nd gen antihistamine |
| what is the brand name of azelastine | astepro |
| what is the therapeutic class of azelastine | anti-allergy |
| what is the pharmacologic class of azelastine | 2nd gen antihistamine |
| what is the brand name of montelukast | singulair |
| what is the therapeutic class of montelukast | anti-asthmatic |
| what is the pharmacologic class of montelukast | leukotriene receptor antagonist |
| what is the MOA of diphenhydramine | blocks histamine receptor |
| what is the MOA of doxylamine | blocks histamine receptor |
| what is the MOA of hydroxyzine | blocks histamine receptor |
| what is the MOA of meclizine | blocks histamine receptor |
| what is the MOA of cetirizine | blocks histamine receptor |
| what is the MOA of loratadine | blocks histamine receptor |
| what is the MOA of desloratadine | blocks histamine receptor |
| what is the MOA of fexofenadine | blocks histamine receptor |
| what is the MOA of azelastine | blocks histamine receptor |
| what is the MOA of montelukast | blocks leukotriene receptor |
| what is a major characteristic of diphenhydramine | anticholinergic effects |
| what is a major characteristic of doxylamine | anticholinergic effects |
| what is a major characteristic of hydroxyzine | anticholinergic effects |
| what is a major characteristic of meclizine | anticholinergic effects |
| what is a major characteristic of cetirizine | anticholinergic effects |
| what is a major characteristic of loratadine | anticholinergic effects |
| what is a major characteristic of desloratadine | anticholinergic effects |
| what is a major characteristic of fexofenadine | anticholinergic effects |
| what is a major characteristic of azelastine | anticholinergic effects |
| what is a major characteristic of montelukast | BBW for neuropsychiatric effects in children |
| what is the brand name of prednisone | N/A |
| what is the therapeutic class of prednisone | anti-inflammatory |
| what is the pharmacologic class of prednisone | corticosteroid |
| what is the brand name of methylprednisolone | SoluMedrol/Medrol |
| what is the therapeutic class of methylprednisolone | anti-inflammatory |
| what is the pharmacologic class of methylprednisolone | corticosteroid |
| what is the brand name of hydrocortisone | Solucortef/cortef |
| what is the therapeutic class of hydrocortisone | anti-inflammatory |
| what is the pharmacologic class of hydrocortisone | corticosteroid |
| what is the brand name of dexamethasone | decadron |
| what is the therapeutic class of dexamethasone | anti-inflammatory |
| what is the pharmacologic class of dexamethasone | corticosteroid |
| what is the brand name of fluticasone | flonase |
| what is the therapeutic class of fluticasone | anti-inflammatory |
| what is the pharmacologic class of fluticasone | corticosteroid |
| what is the brand name of budesonide | Ucreis/Pulmicort |
| what is the therapeutic class of budesonide | anti-inflammatory |
| what is the pharmacologic class of budesonide | corticosteroid |
| what is the brand name of mometasone | nasonex/asmanex |
| what is the therapeutic class of budesonide | anti-inflammatory |
| what is the pharmacologic class of budesonide | corticosteroid |
| what is the brand name of triamcinolone | kenalog/nasocort |
| what is the therapeutic class of triamcinolone | anti-inflammatory |
| what is the pharmacologic class of triamcinolone | corticosteroid |
| what is the brand name of epinephrine | epipen |
| what is the therapeutic class of epinephrine | anaphylaxis agent |
| what is the pharmacologic class of epinephrine | alpha/beta agonist: sympathomimetic |
| what is the MOA of prednisone | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of methylprednisolone | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of hydrocortisone | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of dexamethasone | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of fluticasone | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of budesonide | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of mometasone | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of triamcinolone | decrease inflammatory mediators by changing gene transcription |
| what is the MOA of epinephrine | stimulates the sympathetic nervous system |
| what is a major characteristic of prednisone | metabolic effects |
| what is a major characteristic of methylprednisolone | metabolic effects |
| what is a major characteristic of hydrocortisone | metabolic effects |
| what is a major characteristic of dexamethasone | metabolic effects |
| what is a major characteristic of fluticasone | metabolic effects |
| what is a major characteristic of budesonide | metabolic effects |
| what is a major characteristic of mometasone | metabolic effects |
| what is a major characteristic of triamcinolone | metabolic effects |
| what is a major characteristic of epinephrine | blue to the sky, orange to the thigh |
| what is the brand name of benazepril | lotensin |
| what is the therapeutic class of benazepril | antihypertensive |
| what is the pharmacologic class of benazepril | ACE inhibitor |
| what is the brand name of enalapril | vasotec |
| what is the therapeutic class of enalapril | antihypertensive |
| what is the pharmacologic class of enalapril | ACE inhibitor |
| what is the brand name of fosinopril | monopril |
| what is the therapeutic class of fosinopril | antihypertensive |
| what is the pharmacologic class of fosinopril | ACE inhibitor |
| what is the brand name of lisinopril | prinivil/zestril |
| what is the therapeutic class of lisinopril | antihypertensive |
| what is the pharmacologic class of lisinopril | ACE inhibitor |
| what is the brand name of quinapril | accupril |
| what is the therapeutic class of quinapril | antihypertensive |
| what is the pharmacologic class of quinapril | ACE inhibitor |
| what is the brand name of ramipril | altace |
| what is the therapeutic class of ramipril | antihypertensive |
| what is the pharmacologic class of ramipril | ACE inhibitor |
| what is the brand name of candesartan | atacand |
| what is the therapeutic class of candesartan | antihypertensive |
| what is the pharmacologic class of candesartan | ARB |
| what is the brand name of irbesartan | avapro |
| what is the therapeutic class of irbesartan | antihypertensive |
| what is the pharmacologic class of irbesartan | ARB |
| what is the brand name of losartan | cozaar |
| what is the therapeutic class of losartan | antihypertensive |
| what is the pharmacologic class of losartan | ARB |
| what is the brand name of olmesartan | benicar |
| what is the therapeutic class of olmesartan | antihypertensive |
| what is the pharmacologic class of olmesartan | ARB |
| what is the brand name of telmisartan | micardis |
| what is the therapeutic class of telmisartan | antihypertensive |
| what is the pharmacologic class of telmisartan | ARB |
| what is the brand name of valsartan | diovan |
| what is the therapeutic class of valsartan | antihypertensive |
| what is the pharmacologic class of valsartan | ARB |
| what is the brand name of sacubitril/valsartan | entresto |
| what is the therapeutic class of sacubitril/valsartan | heart failure |
| what is the pharmacologic class of sacubitril/valsartan | ARNI |
| what is the brand name of spironolactone | aldactone |
| what is the therapeutic class of spironolactone | antihypertensive |
| what is the pharmacologic class of spironolactone | MRA |
| what is the MOA of benazepril | blocks conversion of angiotensin 1 to 2 |
| what is the MOA of enalapril | blocks conversion of angiotensin 1 to 2 |
| what is the MOA of fosinopril | blocks conversion of angiotensin 1 to 2 |
| what is the MOA of lisinopril | blocks conversion of angiotensin 1 to 2 |
| what is the MOA of quinapril | blocks conversion of angiotensin 1 to 2 |
| what is the MOA of ramipril | blocks conversion of angiotensin 1 to 2 |
| what is the MOA of candesartan | blocks the receptor where angiotensin 2 binds |
| what is the MOA of irbesartan | blocks the receptor where angiotensin 2 binds |
| what is the MOA of losartan | blocks the receptor where angiotensin 2 binds |
| what is the MOA of olmesartan | blocks the receptor where angiotensin 2 binds |
| what is the MOA of telmisartan | blocks the receptor where angiotensin 2 binds |
| what is the MOA of valsartan | blocks the receptor where angiotensin 2 binds |
| what is the MOA of sacubitril/valsartan | ARB + neprilysin inhibitor blocks action of neprilysin enzyme |
| what is the MOA of spironolactone | blocks receptor where aldosterone binds |
| what is a major characteristic of benazepril | angioedema |
| what is a major characteristic of enalapril | angioedema |
| what is a major characteristic of fosinopril | angioedema |
| what is a major characteristic of lisinopril | angioedema |
| what is a major characteristic of quinapril | angioedema |
| what is a major characteristic of ramipril | angioedema |
| what is a major characteristic of candesartan | hyperkalemia |
| what is a major characteristic of irbesartan | hyperkalemia |
| what is a major characteristic of losartan | hyperkalemia |
| what is a major characteristic of olmesartan | hyperkalemia |
| what is a major characteristic of telmisartan | hyperkalemia |
| what is a major characteristic of valsartan | hyperkalemia |
| what is a major characteristic of sacubitril/valsartan | hyperkalemia |
| what is a major characteristic of spironolactone | hyperkalemia |
| what is the brand name of amlodipine | norvasc |
| what is the therapeutic class of amlodipine | antihypertensive |
| what is the pharmacologic class of amlodipine | DHP-CCB |
| what is the brand name of felodipine | plendil |
| what is the therapeutic class of felodipine | antihypertensive |
| what is the pharmacologic class of felodipine | DHP-CCB |
| what is the brand name of nifedipine | procardia |
| what is the therapeutic class of nifedipine | antihypertensive |
| what is the pharmacologic class of nifedipine | DHP-CCB |
| what is the brand name of diltiazem | cardizem |
| what is the therapeutic class of diltiazem | rate control |
| what is the pharmacologic class of diltiazem | non-DHP-CCB |
| what is the brand name of verapamil | verelan |
| what is the therapeutic class of verapamil | rate control |
| what is the pharmacologic class of verapamil | non-DHP-CCB |
| what is the brand name of atenolol | tenormin |
| what is the therapeutic class of atenolol | antihypertensive |
| what is the pharmacologic class of atenolol | beta blocker |
| what is the brand name of bisoprolol | zebeta |
| what is the therapeutic class of bisoprolol | antihypertensive |
| what is the pharmacologic class of bisoprolol | beta blocker |
| what is the brand name of carvedilol | coreg |
| what is the therapeutic class of carvedilol | antihypertensive |
| what is the pharmacologic class of carvedilol | beta blocker |
| what is the brand name of labetalol | trandate |
| what is the therapeutic class of labetalol | antihypertensive |
| what is the pharmacologic class of labetalol | beta blocker |
| what is the brand name of metoprolol | toprol |
| what is the therapeutic class of metoprolol | antihypertensive |
| what is the pharmacologic class of metoprolol | beta blocker |
| what is the brand name of nebivolol | bystolic |
| what is the therapeutic class of nebivolol | antihypertensive |
| what is the pharmacologic class of nebivolol | beta blocker |
| what is the brand name of propranolol | inderal |
| what is the therapeutic class of propranolol | antihypertensive |
| what is the pharmacologic class of propranolol | beta blocker |
| what is the MOA of amlodipine | blocks calcium channels in peripheral smooth muscles |
| what is the MOA of felodipine | blocks calcium channels in peripheral smooth muscles |
| what is the MOA of nifedipine | blocks calcium channels in peripheral smooth muscles |
| what is the MOA of diltiazem | blocks calcium channels in the heart |
| what is the MOA of verapamil | blocks calcium channels in the heart |
| what is the MOA of atenolol | blocks noradrenergic receptors that are stimulated by endogenous catecholamines |
| what is the MOA bisoprolol | blocks noradrenergic receptors that are stimulated by endogenous catecholamines |
| what is the MOA of carvedilol | blocks noradrenergic receptors that are stimulated by endogenous catecholamines |
| what is the MOA of labetalol | blocks noradrenergic receptors that are stimulated by endogenous catecholamines |
| what is the MOA of metoprolol | blocks noradrenergic receptors that are stimulated by endogenous catecholamines |
| what is the MOA of nebivolol | blocks noradrenergic receptors that are stimulated by endogenous catecholamines |
| what is the MOA of propranolol | blocks noradrenergic receptors that are stimulated by endogenous catecholamines |
| what is a major characteristic of amlodipine | peripheral edema |
| what is a major characteristic of felodipine | peripheral edema |
| what is a major characteristic of nifedipine | peripheral edema |
| what is a major characteristic of diltiazem | bradycardia |
| what is a major characteristic of verapamil | bradycardia |
| what is a major characteristic of atenolol | bradycardia |
| what is a major characteristic of bisoprolol | bradycardia |
| what is a major characteristic of carvedilol | bradycardia |
| what is a major characteristic of labetalol | bradycardia |
| what is a major characteristic of metoprolol | bradycardia |
| what is a major characteristic of nebivolol | bradycardia |
| what is a major characteristic of propranolol | bradycardia |
| what is the brand name of clonidine | catapres |
| what is the therapeutic class of clonidine | antihypertensive |
| what is the pharmacologic class of clonidine | alpha 2 adrenergic agonist |
| what is the brand name of hydralazine | apresoline |
| what is the therapeutic class of hydralazine | antihypertensive |
| what is the pharmacologic class of hydralazine | arterial vasodilator |
| what is the brand name of isosorbide mononitrate | imdur |
| what is the therapeutic class of isosorbide mononitrate | antianginal |
| what is the pharmacologic class of isosorbide mononitrate | vasodilator |
| what is the brand name of nitroglycerin | nitrostat |
| what is the therapeutic class of nitroglycerin | antianginal |
| what is the pharmacologic class of nitroglycerin | vasodilator |
| what is the brand name of doxazosin | cardura |
| what is the therapeutic class of doxazosin | antihypertensive |
| what is the pharmacologic class of doxazosin | alpha 1 blocker |
| what is the brand name of prazosin | minipress |
| what is the therapeutic class of prazosin | antihypertensive |
| what is the pharmacologic class of prazosin | alpha 1 blocker |
| what is the brand name of terazosin | tezruly |
| what is the therapeutic class of terazosin | antihypertensive |
| what is the pharmacologic class of terazosin | alpha 1 blocker |
| what is the MOA of clonidine | prevents sympathetic outflow from CNS |
| what is the MOA of hydralazine | relaxes and dilates arterioles |
| what is the MOA of isosorbide mononitrate | dilates blood vessels |
| what is the MOA of nitroglycerin | dilates blood vessels |
| what is the MOA of doxazosin | blocks alpha 1 receptors in the vascular smooth muscle |
| what is the MOA of prazosin | blocks alpha 1 receptors in the vascular smooth muscle |
| what is the MOA of terazosin | blocks alpha 1 receptors in the vascular smooth muscle |
| what is a major characteristic of clonidine | rebound hypertension |
| what is a major characteristic of hydralazine | coronary heart disease |
| what is a major characteristic of nitroglycerin | headache |
| what is a major characteristic of isosorbide mononitrate | headache |
| what is a major characteristic of doxazosin | orthostatic hypotension |
| what is a major characteristic of prazosin | orthostatic hypotension |
| what is a major characteristic of terazosin | orthostatic hypotension |